Shan Wu
Corporate Officer/Principal presso VIRIDIAN THERAPEUTICS, INC.
Profilo
Shan Wu is currently the Chief Business Officer at Viridian Therapeutics, Inc. Prior to this role, she served as the Vice President & Head of Business Development at Magenta Therapeutics, Inc. from 2021 to 2023.
Dr. Wu completed her undergraduate degree at the University of Virginia and holds a doctorate from the Massachusetts Institute of Technology.
Posizioni attive di Shan Wu
| Società | Posizione | Inizio |
|---|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Corporate Officer/Principal | 30/10/2023 |
Precedenti posizioni note di Shan Wu
| Società | Posizione | Fine |
|---|---|---|
| MAGENTA THERAPEUTICS | Investor Relations Contact | 01/09/2023 |
Formazione di Shan Wu
| University of Virginia | Undergraduate Degree |
| Massachusetts Institute of Technology | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Magenta Therapeutics, Inc. is a biotechnology company, which focuses on improving stem cell transplantation. Its platform includes MGTA-117, MGTA-145, and CD45-ADC. The company was founded by David T. Scadden, Derrick J. Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner on June 17, 2015 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Shan Wu
